Podcasts about Multiple sclerosis

If you're living with MS and wondering what you can do beyond simply managing symptoms, this episode is a powerful place to start.Pam Bartha was diagnosed with multiple sclerosis at just 28 after losing vision in one eye and developing neurological symptoms. She was told MS was incurable and that progressive disability was likely. Instead, she began investigating what might be contributing to illness—and rebuilding her health from multiple directions. She now describes herself as having lived MS-free for 37 years.In this conversation, we explore why Pam believes parasites and other chronic infections deserve greater attention in MS, the nutrition changes that became foundational to her recovery, and how the mind-body connection—including stress, mindset, purpose, and community—fits into a much larger healing picture.You'll also learn what Pam wishes every newly diagnosed MS patient knew, why she believes recovery requires looking beyond any single intervention, and how to begin taking a more active role in your own health without becoming overwhelmed.If you have MS—or love someone who does—start here.Learn from and connect with Pam Bartha: www.livediseasefree.comJoin my free email community for practical healing tools, research, survivor stories, and encouragement between episodes:https://TheRenegadeNutritionist.comThis podcast is for educational purposes only and does not offer medical advice. Guest experiences and opinions are their own, and individual outcomes vary. Consult your licensed healthcare provider before making changes to your diet, medications, supplements, treatment, or health regimen. Reliance on any information provided is solely at your own risk.This podcast explores stories and science around ALS, dementia, MS, cancer, mind body recovery, healing, functional medicine, heart disease, regression, remission, integrative medicine, autoimmune conditions, chronic illness, terminal disease, terminal illness, holistic health, quality of life, alternative medicine, natural healing, lifestyle medicine, and remission from cancer, offering hope and insights for those seeking resilience and renewal.

  Most people don't think about home accessibility until mobility changes force the conversation. But what if you decide to take control of the unknown and design your living space for whatever the future might bring? My guest, Sarah Timmerman, explains how she took total control of her future by designing and building what she calls The House That MS Built—a home engineered from the foundation up to future-proof her independence through smart, universal design and relentless self-advocacy.  We'll also tell you about a research team that identified 4 biomarkers that, together, can help a neurologist understand whether a stem cell therapy is working for their patient weeks before that patient returns to the clinic. We're sharing results of a trial that answered the question, "Can diet actually change what's happening at the cellular level inside the brain?" You'll want to hear these results! And we'll tell you about a research team that has developed a derivative of an HIV medication that restored mobility and vision to mice with the mouse version of MS.  We have a lot to talk about! Are you ready for RealTalk MS??! This Week:  The House that MS Built  :22 Have you downloaded the new RealTalk MS app for your iOS or Android device?   1:16 Researchers at Tisch Multiple Sclerosis Research Center of New York identify 4 biomarkers that can help physicians track the response to stem cell therapy in people living with progressive MS   2:01 New research identifies how gut health can lead to nerve cell damage in MS   4:49 Repurposed HIV medication restores lost function in the mouse model of MS  8:48 Sarah Timmerman shares her story and explains how relentless self-advocacy became the foundation for the House that MS Built  12:55 Share this episode  24:09 Next week  24:29 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/474 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com DOWNLOAD: The RealTalk MS App iOS: https://apps.apple.com/us/app/realtalk-ms/id6769516594 Android: https://play.google.com/store/apps/details?id=com.realtalkms.app&pcampaignid=web_share REGISTER: ECTRIMS Patient Community Day 2026 https://ectrimspatientcommunity.eu STUDY: Effect of Intrathecal Injection of Mesenchymal Stem Cell-Neural Progenitors on Cerebrospinal Fluid Biomarkers in Progressive Multiple Sclerosis https://pmc.ncbi.nlm.nih.gov/articles/PMC13585449 STUDY: High-Fat Diet Promotes T-Cell Mediated Synaptic Dysfunction in Multiple Sclerosis https://link.springer.com/article/10.1186/s12974-026-04049-x STUDY: The Nucleoside Analog Kamuvudine-9 Shows Protective and Therapeutic Efficacy in a Mouse Model of Multiple Sclerosis https://science.org/doi/10.1126/scitranslmed.aei2870 JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 474 Guest: Sarah Timmerman Privacy Policy

Send us Fan MailMorning Prayers ( All Creation Praise God; Draw near to God / resist the devil; Believers in prison - revival; Multiple Sclerosis; Bad weather events; Others) #pray #Jesus #others Thank you for listening, our heart's prayer is for you and I to walk daily with Jesus, our joy and peaceaimingforjesus.comYouTube Channel https://www.youtube.com/@aimingforjesus5346Instagram https://www.instagram.com/aiming_for_jesus/Threads https://www.threads.com/@aiming_for_jesusX https://x.com/AimingForJesusTik Tok https://www.tiktok.com/@aiming.for.jesus

Doug Risher talks with Dr. David Hafler of Yale University about exciting new research into multiple sclerosis and Parkinson's disease. Dr. Hafler discusses how our understanding of MS has changed over the past 50 years, the role of genetics and Epstein-Barr virus, and advances in treatment. They also explore his research into the early warning signs of Parkinson's disease, including loss of smell and sleep disorders, and whether identifying inflammation in the brain earlier could eventually lead to treatments that slow or prevent the disease. Dr. Hafler will discuss these topics in greater detail at “Curing Parkinson's Disease and Multiple Sclerosis,” a free community event this Friday, September 25th, from 5 to 6:30 p.m. at Nantucket Cottage Hospital. 

Send us Fan MailThis week in Just MS News:Alpha-lipoic acid has passed an important interim checkpoint in the phase 3 OCTOPUS trial for progressive MS, while metformin will not continue. This does not yet prove ALA slows disability progression, but it has shown enough potential to keep testing.A new Nature Medicine study also found EBV-related immune changes appearing roughly 30–90 days before confirmed MS relapses. The findings strengthen the link between EBV, B cells and MS activity, but do not prove EBV caused the relapses.European regulators have recommended expanding Ocrevus to people aged 10+ with active relapsing MS. We also cover a newly cleared C-CAR168 CAR-T trial for progressive MS and early Manitoba research into NRG-1 and myelin repair.SOURCESOCTOPUS / Alpha-Lipoic Acid https://www.ucl.ac.uk/news/2026/sep/existing-drug-shows-early-promise-treat-progressive-ms https://ms-octopus.mrcctu.ucl.ac.uk/EBV Before MS Relapse — Nature Medicine https://www.nature.com/articles/s41591-026-04665-3Ocrevus / Pediatric MS https://www.roche.com/media/releases/med-cor-2026-09-18 https://www.ema.europa.eu/en/medicines/human/variation/ocrevusC-CAR168 CAR-T / Progressive MS https://www.neurologylive.com/view/fda-clears-c-car168-trial-refractory-progressive-multiple-sclerosisNRG-1 / Manitoba Research https://umtoday.ca/stories/potential-new-ms-treatment-may-restore-brain-function https://www.nature.com/articles/s41467-026-72639-7Just Multiple Sclerosis https://justmultiplesclerosis.comJust MS News is for education and discussion and is not medical advice. Discuss treatment decisions, supplements or changes to your care with your healthcare team.#MultipleSclerosis #MSNews #ProgressiveMS #MSResearch #Ocrevus #EBV #CART #SPMS #PPMSThe Just MS (Multiple Sclerosis) Show, w host Justin Loizos, is a podcast that connects, educates and tries to uplift others living with multiple sclerosis. It provides real-life stories, interviews, and information about DMTs (disease modification therapies) and updates on research developments.www.justmultiplesclerosis.com

What if clinical trials could evaluate multiple treatment approaches at the same time and adapt as evidence emerges? In this episode of the ECTRIMS Podcast, host Brett Drummond speaks with Prof. Jeremy Chataway of University College London and Prof. Daniel Ontaneda of Cleveland Clinic about multi-arm, multi-stage clinical trials and their potential to make MS research more efficient and responsive. The episode comes at an especially timely moment. This week, interim results from the OCTOPUS trial showed that alpha-lipoic acid will progress to the next stage of the trial, while the metformin arm will be stopped. These results provide an early demonstration of the adaptive approach discussed in this episode — although the conversation itself was recorded before the interim results were available. Together, they discuss: How multi-arm, multi-stage trials differ from traditional clinical trial designs Why these approaches could be particularly valuable in progressive multiple sclerosis How a single trial framework can allow promising treatments to advance while less promising approaches are stopped The potential benefits for recruitment, participant experience and reducing the time between trial phases The statistical and practical challenges involved in designing and running these complex studies How interim outcomes, imaging and biomarkers could help identify promising treatments earlier What the OCTOPUS trial is investigating — and how its design is being used to evaluate potential treatments for progressive MS Whether the same approach could be used to accelerate the development of remyelination and repair therapies As the first OCTOPUS interim results now show, the adaptive design discussed in this episode is not simply theoretical. This episode offers a particularly relevant look at the thinking behind the trial and the methodology being used to determine which treatments should move forward and which should not. This podcast episode is supported by an educational grant from Alexion, AstraZeneca Rare Diseases, Bristol Myers Squibb, Roche, Sanofi, and UCB. Educational grant providers have no input into the podcast series content.

What if a diagnosis could explain your symptoms without defining your future? In this episode of the Health Detective Podcast, Michele Scarlet sits down with Dr. Sierra Bains, Doctor of Physical Therapy, Functional Diagnostic Nutrition Practitioner, best-selling author of Rooted, and founder of Lightstyle, for a powerful conversation about Multiple Sclerosis, root cause healing, nervous system health, chronic stress, and functional health. Sierra shares the story of being diagnosed with Multiple Sclerosis at 24 while completing her doctorate during the COVID-19 pandemic. Despite being a competitive bodybuilder who closely tracked her nutrition, sleep, movement, and health metrics, she suddenly experienced severe pain, nausea, nerve pain, tingling, vibrations, confusion, and debilitating symptoms that dramatically changed her life. After struggling to find answers through standard medical care, Sierra began exploring a different approach. With support from a practitioner, she focused on reducing inflammation, improving diet, circadian rhythm, supplementation, and stress management. Her symptoms gradually improved, and her experience ultimately led her to Functional Diagnostic Nutrition and a deeper understanding of root cause health. Michele and Sierra explore how the body can communicate through symptoms, why stress is more than simply “feeling stressed,” and how physical, emotional, and environmental stressors can accumulate in the body. They discuss the nervous system, autoimmune symptoms, hormone signals, lifestyle, functional health, and why addressing the reasons behind a symptom may be more meaningful than simply managing the symptom itself. The conversation also examines practitioner education, the dangers of overcomplicating health protocols, supplement overload, health tracking, technology consumption, and the importance of helping clients develop resilience and trust in their bodies. Sierra shares how she moved from restrictive protocols toward greater metabolic flexibility, resilience, and the ability to enjoy real life without constantly managing every symptom. This episode is for anyone interested in Functional Diagnostic Nutrition, root cause healing, nervous system health, chronic health challenges, holistic health, functional medicine, and a more empowered approach to understanding the body. Connect with Dr Sierra Bains https://www.instagram.com/drsierrabains/ 00:00 From Chronic Symptoms to Root Cause Healing 06:55 Multiple Sclerosis Diagnosis: What Happened Next 14:10 Why Your Diagnosis May Not Be the Root Cause 20:02 How Chronic Stress Affects the Body 23:19 The Stress Bucket: What Happens When It Overflows 24:46 How Digital Overload Affects Your Nervous System 25:58 Why Getting Healthy Needs a Bigger Purpose 27:49 How to Make Better Decisions About Your Health 29:15 Why Chronic Disease Is Increasing 32:02 Environmental Toxins: How Much Is Too Much? 35:25 How to Build Resilience and Trust Your Body Again 40:01 Can Trying to Be Healthy Make You More Stressed? 43:32 How to Stop Outsourcing Your Health ⚠️ DISCLAIMER This content is for education only and is not medical advice. Always consult your healthcare provider before making changes.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of dynamic and significant advancements across the industry, from strategic acquisitions to regulatory shifts and scientific innovations. In a bold move, Novartis has acquired Sironax's blood-brain barrier delivery platform for $125 million. This acquisition marks a strategic enhancement in Novartis's ability to deliver therapies directly to the brain, overcoming one of the most formidable challenges in treating neurological disorders. The potential to deliver antibodies and other therapeutic agents effectively across this barrier could lead to groundbreaking treatments for conditions like Alzheimer's disease and multiple sclerosis. This reflects a broader industry trend emphasizing improved drug delivery systems to boost treatment efficacy and patient outcomes. On the clinical advancement front, Sling Therapeutics has raised $123 million in a Series C funding round aimed at propelling its oral therapy for thyroid eye disease forward. Unlike traditional intravenous treatments, this oral therapy offers a more convenient option for patients, potentially improving adherence and quality of life. Meanwhile, Circle Pharma's $92.5 million Series E funding will support the development of its cyclin D1 inhibitor for breast cancer, showcasing innovation in oncology through the use of macrocycles that could provide more effective treatments with fewer side effects. Investments in AI and machine learning are also reshaping the landscape. Ginkgo Bioworks' collaboration with Novo Nordisk to construct an autonomous lab highlights the increasing role of automation in optimizing R&D productivity. Mithrl's $20 million Series A round further underscores this shift, focusing on developing an AI infrastructure platform for streamlined biopharma drug discovery processes. The regulatory environment continues to evolve with notable challenges. BioMarin has discontinued Phase 2 development of Voxzogo in Noonan syndrome due to shifting treatment landscapes, illustrating the dynamic nature of therapeutic development. Similarly, Novartis's halt on its TREM2 stabilizer after a Phase 2 failure in ALS research points to the complexities inherent in neurodegenerative disease studies. Maat Pharma faced a setback when its appeal was rejected regarding the EMA's negative opinion on its graft-versus-host disease candidate, Xervyteg. This instance highlights the stringent regulatory hurdles companies must navigate to bring novel therapies to market. Amid these developments, Gilead Sciences is strategically expanding into oncology and inflammation. Through several acquisitions, Gilead has diversified its portfolio significantly, emphasizing oncology as a central focus area given its high potential for addressing unmet needs and offering substantial returns on investment. Legend Biotech's appointment of Ingrid Zhang as CEO signals a strategic push into the competitive CAR-T cell therapy market. These therapies represent a revolutionary approach in personalized medicine for cancer treatment, with Legend positioning itself for growth and innovation. Bristol Myers Squibb and Ono Pharmaceutical are preparing to contest Amgen's efforts to launch a biosimilar for their oncology blockbuster Opdivo. This reflects broader competitive dynamics within the biologics market where biosimilars promise more cost-effective options, potentially reshaping market shares and pricing strategies. Manufacturing innovations are also at play with Ori Biotech securing a $120 million deal for an automated production platform in cell therapy manufacturing. Such advancements are crucial as cell therapies become more mainstream, necessitating scalable solutions that maintain quality while meeting demand. Operational expansions continue as Reckitt Benckiser allocates $600 million to upgrade its US operations, fostering innovation across health and hygiene product lines—an industry trend towards integrating R&D with manufacturing prowess to drive new product development. While challenges persist—illustrated by Novartis's multiple trial failures—the pharmaceutical and biotech sectors remain resilient with adaptive strategies focused on innovation. The ongoing advancements underscore not only scientific exploration but also strategic maneuvering amidst evolving regulatory landscapes. As AI reshapes talent acquisition strategies and technological advancements accelerate drug discovery processes, companies must navigate complex global health ecosystems poised for transformative growth. The focus remains on improving patient outcomes through cutting-edge science while balancing innovation with strategic realignment. Thank you for tuning into Pharma Daily—where we keep you abreast of pivotal industry shifts shaping the future of healthcare. Join us again tomorrow as we continue exploring these exciting developments impacting patient care worldwide.Support the show

Ask Flora Funga Podcast anything OR Leave a ReviewRichard Capalbo the Founder of Rooted Fox Wellness, a wellness company focused on functional mushrooms. He makes a Lion's Mane Functional Chocolate and Lion's Mane Functional Capsules- supporting Mood, Focus, Memory, and Cognitive Function. He founded the company along his wellness journey after being diagnosed with Multiple Sclerosis about 10 years ago. Rooted Fox Wellness is grounded in years of working with functional mushrooms and real-world use, our third-party tested products are designed to be effortless, enjoyable, and effective.*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.Rooted Fox WellnessI got a new phone number to text in with any questions, comments, or photos!727-477-5974 Support the showText (727) 477-5974 Flora Funga Phone with your questions, comments, concerns, and IDs Flora Funga: Calm & Collected Tincture — Flora Funga PodcastGoFundMEIf you like the podcast please think of donating to Keep the show happening  $keenie19 on Cash AppFollow my other social media sites to interact and engage with me:Email me to be on the podcast or inperson Interview: floraandfungapodcast@gmail.comFacebookInstagramTwitterTikTokYouTubePatreon---------------------------------------------------------------------------Zbiotics: "FLORA10"Drink ZBiotics before drinking alcohol-Alcohol produces acetaldehyde, a byproduct that your next day...

  We are less than 40 days away from MSToronto2026—the joint ECTRIMS/ACTRIMS Scientific Congress. While the congress brings together the world's leading MS researchers and clinicians, Patient Community Day —in person and online—is designed specifically for people affected by multiple sclerosis. This week, Dr. Jennifer Graves and Brett Drummond join me to preview what to expect from Patient Community Day 2026. With less than 50 days until the midterm elections in the United States, the National MS Society is hosting a webinar you can't afford to miss, titled MS Advocacy in Action: What the 2026 Elections Could Mean for Healthcare Policy and Access to Care. We'll tell you how to register (And we'll remind you why you should!). A 22-country survey of over 17,000 people with MS revealed that the invisible symptoms of MS remain critically unaddressed. We're sharing the details of this landmark survey. We're sharing early trial results of a precision red blood cell therapy designed to halt myelin attacks without shutting down the immune system. We'll tell you about the German research team that's repurposing a common, low-cost medication into a skin patch designed to jumpstart natural remyelination. And we'll share a study showing how simple, short voice recordings can predict long-term cognitive changes and brain volume loss in people living with MS. We have a lot to talk about! Are you ready for RealTalk MS??! This Week:  A preview of Patient Community Day 2026  :22 The National MS Society is hosting a webinar you shouldn't miss   1:32 Results of a landmark survey reveal critical unmet needs among people living with MS   5:27 A new approach to preventing MS inflammatory attacks while keeping the rest of the immune system intact   8:27 Could a skin patch successfully promote myelin repair?  11:42 Can analyzing regular speech predict future brain atrophy in people with MS?  14:34 Dr. Jennifer Graves and Brett Drummond give us a preview of Patient Community Day 2026  18:53 Share this episode  33:01 Next week  33:20 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/472 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com REGISTER: ECTRIMS Patient Community Day 2026 https://ectrimspatientcommunity.eu WEBINAR: Advocacy In Action: What the 2026 Elections Could Mean for Healthcare Policy and Access to Care https://nmss.quorum.us/event/37051 STUDY: Impact of Multiple Sclerosis Symptoms Survey: Patient-Reported Data on the Prevalence, Burden, and Management of Multiple Sclerosis Symptoms in Europe https://journals.sagepub.com/doi/10.1177/13524585261480514 STUDY: Treatment of Multiple Sclerosis with Peptide-Coupled Red Blood Cells Induces Antigen-Specific T Regulatory Cells https://pnas.org/doi/abs/10.1073/pnas.2614908123 STUDY: Automated Speech Analysis Reveals Progressive Linguistic Changes Associated With Subsequent Gray Matter Loss in Multiple Sclerosis https://journals.sagepub.com/doi/full/10.1177/13524585261477213 JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 472 Guest: Brett Drummond and Dr. Jennifer Graves Privacy Policy

When Brenda Snow was diagnosed with Multiple Sclerosis 30 years ago, she had to grieve the life she thought she'd have before she could reimagine who she was meant to become. Now a leading patient advocate and best-selling author of Diagnosed, Brenda shares how living with MS led her to transform deep loss into purpose, build a groundbreaking healthcare agency, and discover that a diagnosis isn't the end of your story; it's the beginning of rebuilding with intention, resilience, and joy. ---✨ Grief & Rebirth: Healing Resources & Tools ✨

The blood–brain barrier is a highly specialised interface that regulates the movement of cells, molecules and nutrients between the circulation and the central nervous system. But what happens when this critical barrier becomes dysfunctional in multiple sclerosis? In this episode of the ECTRIMS Podcast, host Brett Drummond speaks with Prof. Elga de Vries of Amsterdam UMC and MS Center Amsterdam about the evolving science of blood–brain barrier dysfunction in MS. They explore how the blood–brain barrier functions in health, how its disruption relates to immune cell infiltration and inflammatory disease activity, and why research increasingly suggests these changes may remain relevant across different stages of MS. The conversation also looks at innovative blood–brain barrier-on-a-chip models, how existing MS treatments interact with the barrier, and emerging approaches designed to transport therapies more effectively into the CNS. Finally, they consider an intriguing future direction: could strengthening the blood–brain barrier itself become part of the therapeutic strategy for MS? This podcast episode is supported by an educational grant from Alexion, AstraZeneca Rare Diseases, Bristol Myers Squibb, Roche, Sanofi, and UCB.

Six years of symptoms. Six years of searching for answers. Six years of a body that kept speaking while no one could—or would—put the pieces together.That's where Rachel Hayden's MS journey began, and it's a story that will sound painfully familiar to anyone who has been dismissed, doubted, or told to wait a little longer. In this episode, Lyndsay Soprano sits down with Rachel, a type 1 diabetic, MS warrior, podcast host, and founder of the Spoonful of Strength community, to talk about what it really looks like to navigate invisible illness in a world that can't see what you're carrying. They go into the six-year road to diagnosis, the medical gaslighting that came with it, the undiagnosed muscle issues that still affect Rachel's breathing and mobility today, and the mental health spiral that chronic illness quietly creates when nobody is paying attention. But this conversation doesn't stay in the dark. Rachel shares how to learn to speak to yourself the way you would speak to someone you love. It sounds simple. It isn't. And it changes everything. This episode is for anyone tired of being last on their own list.Episode Highlights:(00:01) Lyndsay opens up about the spiral of dread and showing up every day(02:44) Introducing Rachel Hayden(03:37) Rachel's type 1 diabetes diagnosis at 19(04:43) The first MS symptoms and the ER visit(06:04) Six years of being dismissed and not diagnosed(07:26) "Are they waiting for me to get worse?"(08:36) The self-doubt that medical gaslighting plants in you(09:19) The testing that finally confirmed MS(39:09) What chronic pain has cost Rachel and how she loves herself daily(41:25) Slowing down, saying no and putting yourself first(43:11) Where to find Rachel and The SpoonFulll Show(44:39) Rachel's closing message to speak kindly to yourselfFind Rachel Hayden Online Here:Instagram: @spoonfullofstrengthFacebook: SpoonFull of StrengthYouTube: @TheSpoonFullShowTikTok: @spoonfull.of.strengthPodcast: The SpoonFull ShowFind Giving Pain Purpose Online Here:Website: givingpainpurpose.comInstagram: @givingpainpurposeFacebook: The Giving Pain Purpose PodcastLinkedIn: Lyndsay SopranoYouTube: @givingpainpurposeShop: thegivingpainpurposeshop.comSubscribe on YouTube | Merch Shop is OPEN!! | COMING SOON: The Pain Hub - A Women's Healing Community. Subscribe Now!Unfiltered convos. Dark humor. Real healing. This is where pain meets purpose — and you're not doing it alone.++Want to be a guest on Giving Pain Purpose with Lyndsay Soprano? Send her a message on PodMatch, here: Be a Guest on The Show

Relapses make life with MS unpredictable. Understanding what they are, why they happen, and how best to manage them can make a relapse less scary and easier to navigate.   This week, Dr. Gabriela Karolidis, a board-certified neurologist and neuroimmunologist at Thomas Jefferson University, joins us for a deep dive into MS relapses. The MS International Federation has just updated the Atlas of MS, showing more than 3 million people living with MS worldwide. We're sharing the details behind the new numbers. We'll also share a study showing how wearable activity trackers add a dimension of real-world data that provides a more complete picture of an individual's mobility throughout the day. We'll tell you about research on Vitamin D supplements that fails to determine whether they are beneficial for people living with MS. We're sharing study results showing that social and socioeconomic factors clearly affect cognitive function among people living with MS.  We're also sharing results from a nationwide study in Denmark that focused on whether high-efficacy DMTs affect progression independent of relapse activity (PIRA). And we'll tell you about a fall prevention study that you may be eligible to participate in (compensation provided!). We have a lot to talk about! Are you ready for RealTalk MS??! This Week: Navigating a relapse  :22 Global MS prevalence surpasses 3 million   :57 A study shows that wearable activity trackers help create a more complete picture of an individual's mobility   6:38 Researchers attempt to determine whether Vitamin D supplements help people living with MS   10:14 A study provides evidence that social and socioeconomic factors impact cognitive function in people living with MS  13:58 A nationwide study in Denmark focuses on whether high-efficacy disease-modifying therapies have an impact on progression independent of relapse activity (PIRA)  17:20 You may be eligible to participate in a fall prevention study (compensation is provided)  21:11 Dr. F. Gabriela Karolidis takes us on a deep dive into MS relapses  22:58 Share this episode  37:52 Next week  38:12 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/471 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com STUDY: Global Prevalence of Multiple Sclerosis Surpasses 3 Million: 2024 Update of the Multiple Sclerosis International Federation Atlas of MS https://journals.sagepub.com/doi/10.1177/13524585261479954 RESOURCE: Multiple Sclerosis International Federation Atlas of MS https://msif.org/atlas STUDY: Diurnal Step Count Patterns in Progressive Multiple Sclerosis https://journals.sagepub.com/doi/10.1177/13524585261475910 STUDY: Vitamin D Supplementation and Its Effect on Relapse Frequency and MRI Activity in Adults With Multiple Sclerosis: A Systematic Review https://onlinelibrary.wiley.com/doi/10.1002/brb3.71692 STUDY: Social and Socioeconomic Factors and Cognitive Outcomes in Multiple Sclerosis https://sciencedirect.com/science/article/pii/S221103482600475X STUDY: Effectiveness of Escalation Versus Early High-Efficacy Therapies on Progression Independent of Relapse Activity In Multiple Sclerosis: A Danish Nationwide Study https://neurologyopen.bmj.com/content/8/2/e001690 PARTICIPATE: University of Illinois Disability, Participation, and Quality of Life Research Laboratory Fall Prevention Study Email: DPQoL-FallPrev@illinois.edu REGISTER: ECTRIMS Patient Community Day https://ectrimspatientcommunity.eu JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 471 Guest: Dr. Gabriela Karolidis Privacy Policy

In this episode, we talk with Kristina Guse from the National Multiple Sclerosis Society about multiple sclerosis, the support available for people affected by the disease, and the upcoming MS Taste of Generosity event at the Royal Oak Farmers Market. The National MS Society was founded in 1946 and serves people living with MS as well as their families, caregivers, and friends. MS is an unpredictable disease of the central nervous system that can affect the brain, spinal cord, and optic nerves. Symptoms can vary widely from person to person and can change from day to day. The exact cause of MS is still unknown. Kristina shares how she first joined the organization early in her career and later returned in 2014. Between both periods, she has spent about 18 years with the National MS Society. What began as a job became a major part of her life. She met her husband through an MS Society golf event, and her daughter now volunteers at events as well. Over the years, Kristina has also met many people living with MS, which has made the mission much more personal. We also talk about the MS Navigator Program. People living with MS, family members, caregivers, and others can connect with a navigator by phone, email, appointments, or online chat. The program helps people find information, resources, and support. Kristina then gives us a look at the fifth annual MS Taste of Generosity, happening September 11 at the Royal Oak Farmers Market. The event features 65 Michigan food and beverage vendors, ranging from established brands like Faygo, Better Made, and Ray's Ice Cream to smaller businesses trying to introduce their products to new customers. The vendors provide samples rather than selling products. Once guests purchase admission, they can sample everything without buying additional tasting tickets. General admission is $50, while the $100 VIP ticket provides entry an hour early at 5:30 p.m., access to a VIP pavilion, seating, a private bar, swag, and other perks. Kids 12 and under attend free, and the event includes children's activities. The event raises about $120,000 each year for the National MS Society. Kristina also highlights Red Hatch Chili, Vander Mill Cider, and newcomer Good Energy Protein Bars as examples of participating vendors. Taste of Michigan Website: https://bit.ly/TOG-MI National MS Society Website: https://www.nationalmssociety.org/ (00:00) Intro (00:45) National MS Society and Multiple Sclerosis 101 (02:50) Kristina Guse's Connection to the MS Society (05:28) Supporting Families and Caregivers (06:50) The MS Taste of Generosity (07:10) How Taste of Generosity Started (08:11) Michigan Food and Beverage Vendors (08:52) One Ticket Includes All Sampling (09:23) Family Friendly Admission and Kids Activities (10:53) What VIP Admission Includes (11:44) Local Businesses Supporting the Event (12:29) Favorite and New Vendors Learn more about the Royal Oak Chamber of Commerce: https://www.royaloakchamber.com/Connect with our host:Jon Gay from JAG in Detroit Podcasts - http://www.jagindetroit.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of Resiliency Radio with Dr. Jill, Dr. Jill Carnahan sits down with researcher and collaboration architect Nikki Schultek to explore an often-overlooked contributor to chronic disease: persistent infections and their impact on inflammation, immunity, and the brain. Drawing from her own experience with severe chronic illness, Lyme disease, Chlamydia pneumoniae, and autoimmunity, Nikki shares how her personal health journey led her into research and a mission to connect scientific disciplines that too often operate in isolation. Together, they explore the emerging concept of the pathobiome, the potential infectious drivers of Alzheimer's and other neurodegenerative diseases, the challenges of diagnosing persistent infections, and why understanding the body as an interconnected ecosystem could transform the future of chronic illness research and treatment.

Get ready to fix your bow tie and walk-and-talk, because we're diving into the legendary Season 2 finale stretch of The West Wing! In this episode of the podcast, we are recapping Season 2, Episodes 19 through 22 —including "Bad Moon Rising," "The Fall's Gonna Kill You," "18th and Potomac," and the undisputed masterpiece "Two Cathedrals."  From Mrs. Landingham's heartbreaking storyline to President Bartlet screaming at God in Latin, we are breaking down all the high-stakes political drama, witty Aaron Sorkin dialogue, and emotional wreckage. Why You Can't Miss This Episode The MS Crisis Explodes: We track the fallout as Jed Bartlet finally reveals his Multiple Sclerosis diagnosis to his staff and the public. Remembering Mrs. Landingham: Grab your tissues as we discuss one of the most devastating and impactful character departures in television history. "Two Cathedrals" Breakdown: We deep-dive into why this is widely considered one of the greatest television episodes ever filmed. Behind-the-Scenes Trivia: Amanda did some digging on behind the scenes fun facts and we're full of them in this epsiode. Whether you are a first-time viewer or a seasoned West Wing fanatic, we're glad you're here! And don't forget to like, subscribe, and leave a review. It feeds the algorithm and their egos! 

Welcome to the Plant-Based Canada Podcast! In today's episode, we're joined by Karen Lee to discuss plant-based practices for autoimmune disease and her recently published book. Karen is a retired intensive care nurse and award-winning plant-based nutritionist who has a passion for tasty food that's also good for health. After a diagnosis of Multiple Sclerosis (also known as MS)  in 2016, she uses diet and lifestyle to manage her condition and shares this knowledge with others through her website – The Sensitive Foodie Kitchen – as well as workshops, talks, online classes and one to one sessions.She published her first book Eat Well Live Well with The Sensitive Foodie in 2019. Her second book, Healing From The Inside Out, was published in January 2026, and explores the benefits of a whole-food plant-based diet for autoimmune disease. Karen is a Health Coach, a facilitator for the charity Overcoming MS that provides an accessible lifestyle medicine program that supports people with MS and a Nutrition and Lifestyle Medicine Educator for Plant Based Health Professionals UK. Most importantly, Karen loves creating and sharing nourishing plant-based recipes that everyone can enjoy.Websiteswww.thesensitivefoodiekitchen.comwww.instagram.com/the.sensitive.foodie/www.facebook.com/TheSensitiveFoodie/https://www.linkedin.com/in/karen-lee-sensitive-foodie/https://www.youtube.com/@TheSensitiveFoodieKitchen Resources:Karen Lee's Website & Book: https://thesensitivefoodiekitchen.com/healing-from-the-inside-out/Kate's Case Study:  https://pubmed.ncbi.nlm.nih.gov/34366737/Case Study: https://journals.sagepub.com/doi/10.1177/15598276221141403Plants for Joints research: https://pubmed.ncbi.nlm.nih.gov/38413171/ Plant-Based Canada's Socials:Instagram  (@plantbasedcanadaorg)Facebook (Plant-Based Canada, https://m.facebook.com/plantbasedcanadaorg/)Website  (https://www.plantbasedcanada.org/)X / Twitter @PBC_orgBonus PromotionCheck out University of Guelph's online Plant-Based Nutrition Certificate. Each 4-week course will guide you through essential plant-based topics including nutritional benefits, disease prevention, and environmental impacts. You can also customize your learning with unique courses such as Plant-Based Diets for Athletes and Implementing a Plant-Based Diet at Home. As the first university-level plant-based certificate in Canada, you'll explore current research, learn from leading industry experts, and join a community of like-minded people. Use our exclusive discount code PBC2026 to save 10% on all Plant-Based Nutrition Certificate courses. uoguel.ph/pbn.Thank you for tuning in! Make sure to subscribe to the Plant-Based Canada Podcast so you get notified when new episodes are published. This episode was hosted by Stephanie Nishi RD, PhD.Support the show

In this episode of the Brain Health Podcast, co-host Dr. Katy Peters is joined by CNN's award-winning chief national correspondent, John King. John shares what it's been like to build a demanding career while living with multiple sclerosis (MS), and why community, support, and self-care have been essential to his journey. Later, Dr. Peters speaks with Dr. Robert Shin, professor of neurology and director of the Multiple Sclerosis and Clinical Neuroimmunology Division at UVA Health. Dr. Shin discusses the latest advances in MS treatment and research, addresses persistent health disparities, and explains how MS can affect men differently.   Brain Health Podcast Episodes on Similar Topics Continuing the Race to Erase MS with Nancy Davis Exploring Nutrition, Lifestyle, and Pediatric Multiple Sclerosis with Dr. Emmanuelle Waubant Voices from the Multiple Sclerosis Community   We want to hear from you! Have a question or want to hear a topic featured on the Brain Health Podcast? ·       Record a voicemail at 612-928-6206 ·       Email us at podcast@brainhealth.com   Social Media Guests: John King @johnkingcnn; Dr. Shin @uvahealth Hosts: Dr. Daniel Correa @neurodrcorrea; Dr. Katy Peters @KatyPetersMDPhD

“Those moments are teachable, not only for others but for ourselves.” Sex. Drugs. Rock and roll. Yep, we're going there. Well, sort of. In this episode of A Couple Takes on MS, we're talking about three recent experiences that reminded us how living with Multiple Sclerosis can turn everyday moments into opportunities to advocate, adapt, learn, and sometimes laugh. Join us as we take on: Sex, disability, and assumptions — Why the way healthcare providers ask personal questions matters, and how one appointment became an unexpected teachable moment. The power of language — Why “wheelchair bound” doesn't describe Jennifer's reality and how her wheelchair represents mobility, freedom, and independence. Drugs, insurance, and self-advocacy — Dan's experience finding another way to access a medication his insurance wouldn't cover and why it pays to ask about your options. Staying informed about your care — How conversations with healthcare providers and the MS community can help us continue learning about medications, treatments, and their long-term effects. When accessibility doesn't go according to plan — How our concert seating mistake, some wonderful Pine Knob staff, and a little patience helped turn potential frustration into an unforgettable night of rock and roll. Yes, sex, drugs, and rock and roll sparked this conversation, but the real lesson is something we continue learning again and again while living with MS: keep asking questions, keep advocating for yourself, and leave a little room for grace along the way. From the ACTOMS blog Want the full story behind the “rock and roll” part of this episode? Jennifer shares how a ticketing mistake, some incredible people, and a little patience turned an accessibility challenge at Pine Knob Music Theatre into one of our favorite concert experiences. Read Sometimes accessibility looks like community *** Thank you for listening to A Couple Takes on MS. We're grateful you're moving forward with us one step, one roll, and one story at a time. If you enjoyed this episode, please consider following the podcast, leaving a rating or review, and sharing it with someone who could use a little encouragement today.

Multiple sclerosis (MS) is a chronic autoimmune neurological disorder that affects the central nervous system, specifically the brain and spinal cord. MS is managed by disease modifying therapies (DMTs), symptom management medications, and lifestyle interventions. Lifestyle interventions focus on six pillars of brain health: nutrition, exercise, sleep, stress management, social connection and avoidance of harmful substances. Learn more. pacificms.org

On this episode of Autism for Badass Moms, host Rashidahsits down with Lexus Sheffield, a 29-year-old mother of four from Texas.Lexus is the mother of 4-year-old twins, Journie andJamarion, Jr., who were both diagnosed with autism in May 2025. As she navigated developmental concerns, services, and learning how to advocate for both of her children, Lexus was also facing a life-changing diagnosis of her own.In 2024, Lexus was diagnosed with Multiple Sclerosis.In this candid conversation, Lexus opens up about what itwas like learning that both of her twins were autistic, recognizing their early developmental differences, navigating Early Childhood Intervention, and confronting her own declining health while continuing to care for her family.She also shares how her experience with MS has changed theway she views strength, motherhood, and self-care.  In this episode, we discuss: 0:00 – Meet Lexus1:00 – Twins' NICU journey and early signs of autism5:26 – Fight to get both twins properly evaluated9:30 – Health crisis dismissed by doctors13:30 – Multiple Sclerosis diagnosis18:00 – Burnout 22:15 – Therapy, Part-time work, and starting CrossFit24:53 – How the twins are thriving now31:41 – Reach out to Lexus33:20 – Advice for overwhelmed moms  Connect with Lexus Facebook: Lexus LynetteInstagram: www.instagram.com/lexuslynette If this episode resonated with you:-Follow the Autism for Badass Moms Podcast-Leave a review to help other autism moms find thiscommunity-Share this episode with a parent who may feel unseen ormisunderstood Follow Us: Instagram: www.instagram.com/theabmpodcastFacebook: www.facebook.com/theabmpodcast 

Cognitive changes in MS—fluctuations in processing speed, memory, and executive function—can significantly impact daily life, yet they're often misunderstood or overlooked in routine clinical exams. This week, we are joined by Dr. Anna Kratz, clinical psychologist and Professor in the Department of Physical Medicine and Rehabilitation at the University of Michigan, to discuss actionable, evidence-based ways to navigate cognitive challenges.  Dr. Kratz breaks down the latest findings from the CogDetect-MS study, exploring how daily symptom fluctuations, complex medication regimens, and common substances like caffeine and cannabis influence brain fog. She also shares practical compensatory workarounds and introduces a no-cost digital self-management resource, My MSToolKit. We'll also explain the new framework for describing MS that's been proposed by the International Advisory Committee on Clinical Trials in Multiple Sclerosis. We're sharing study results that reveal why detecting even a single silent lesion on an MRI should trigger an immediate conversation about stepping up to high-efficacy therapy. And we'll tell you about 2 advanced MRI markers that can predict future cognitive decline — even in the absence of any relapses or new lesions on MRI. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: Maintaining and improving cognitive function  :22 The International Advisory Committee on Clinical Trials in Multiple Sclerosis calls for updating the way MS is described   1:12 A study provides evidence for switching your DMT when there's even a single silent lesion on your MRI   6:53 Scientists identify two MRI markers that can predict future cognitive decline in early relapsing-remitting MS   10:53 Dr. Anna Kratz discusses maintaining and improving cognitive function  15:33  Share this episode  42:13 Next week  42:33 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/469 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com PAPER: Towards a Biologically Informed Description of Multiple Sclerosis Disease Course -- A Roadmap for Transition https://rdcu.be/fxBw1 STUDY: Treatment Escalation After Clinically Silent MRI Lesions in Relapsing-Remitting Multiple Sclerosis https://academic.oup.com/brain/advance-article/doi/10.1093/brain/awag252/8741305 STUDY: Paramagnetic Rim Lesions and Choroid Plexus Volume at Diagnosis Are Associated With Cognitive Progression Independent of Relapse and MRI Activity in Early Relapsing-Remitting Multiple Sclerosis https://onlinelibrary.wiley.com/doi/10.1002/acn3.70448 REGISTER: ECTRIMS Patient Community Day https://ectrimspatientcommunity.eu JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 469 Guest: Dr. Anna Kratz Privacy Policy

Why would a neurologist recommend an infusion instead of a pill, and what should patients expect when they arrive for treatment? Neuro infusion therapy can be used for conditions including multiple sclerosis, myasthenia gravis and Alzheimer's disease, but the process can feel unfamiliar or intimidating at first.In this episode of Baptist Health Talk, host Dr. Anthony Gonzalez speaks with Janisse Marin and Leah Marcelin about how neurological infusion therapy works, why it may be recommended, and how care teams help patients through treatment. What neuro infusion therapy is and how it differs from chemotherapy  Why an infusion may be chosen instead of an oral medication  What happens before, during and after an infusion appointment  Common side effects and how patients are monitored for reactions  How infusion therapy is used for multiple sclerosis, myasthenia gravis and Alzheimer's disease  Why some treatments are designed to slow disease progression rather than immediately relieve symptoms  How education and a coordinated care team can make treatment less overwhelmingHost:Anthony Gonzalez, M.D.Chief of Surgery, Baptist Health Baptist HospitalMedical Director of Bariatric Surgery, Baptist HealthGuests:Janisse P. Marin RN, MSNChief Nursing Officer/Assistant Vice President Baptist Outpatient ServicesHalena Leah Marcelin, PharmDAssistant Vice President, Pharmacy Business Affairs & DevelopmentBaptist HealthIf you found this episode helpful, we recommend the following for additional information:Infusion Care for Osteoporosis: What Patients Should KnowThe Power of Infusion Therapy: What You Need to Know

Episode 26-33 Is Insulin Resistance The Greatest Threat To Your Health? Nearly EVERY chronic disease is strongly linked to Insulin Resistance. Or, stated another way… As you age, Insulin Resistance may be THE factor that causes you to suffer with one or more of the following conditions: High Blood Pressure, Diabetes, Alzheimer's, Stroke, Parkinson's, Fibromyalgia, Multiple Sclerosis, Obesity, Heart Disease, Autoimmune Disorders, Vision Problems, Kidney Failure, Neuropathy, Bipolar Disorder, Depression.  On this episode I address the basics regarding Insulin Resistance. Specifically I ask 5 questions that you need to know the answers to should you desire to live a long and HEALTHY life:   1) What is Insulin Resistance? 2) Why is it so harmful? 3) What causes it? 4) How can it be corrected? 5) How do you know if you have it?   Give this episode a good listen if you want to prevent, and possibly reverse, Insulin Resistance and the negative health consequences that come with it. And, as always, be sure to share this episode with a friend.  Thanks!  ———————- Want to learn more? Continue the conversation regarding this episode, and all future episodes, by signing up for our daily emails. Simply visit: GetHealthyAlabama.com  Once there, download the "Symptom Survey" and you will automatically added to our email list. ———————- Also, if you haven't already, we'd appreciate it if you'd subscribe to the podcast, leave a comment and give us a rating. (Thanks!!!)  

               * This podcast is for informational and educational purposes only. It is not intended to diagnose or treat any disease. Please consult with your health care provider before making any health-related changes.

Q-Bank: https://www.patreon.com/highyieldfamilymedicineIntro (0:35),Transient Ischemic Attack (2:10),Ischemic Stroke (4:47),Hemorrhagic Stroke (14:31),Seizures (17:33),Meningitis (20:40),Encephalitis (22:29),Increased Intracranial Pressure and Intracranial Masses (23:23),Multiple Sclerosis (25:35),Movement Disorders (27:56),Practice Questions (31:22)

Imagine your spouse or significant other has been diagnosed with MS...shortly after you were diagnosed with stage IV colon cancer, and given just a 15% chance of survival. All of a sudden, the roles of patient and care partner are up for grabs -- and they change with almost daily frequency.  That's exactly the scenario my guest, Kathleen Silva, faced. Kathleen is joining me to discuss how she and her husband, Rick, survived and thrived amid that frightening chaos. (Spoiler alert -- no one died!)  We'll also tell you about an investigational drug that's the first to promise neuroprotection during an MS relapse. We're sharing study results that show people with MS who meet the medical criteria aren't jumping on the GLP-1 bandwagon. We'll provide compelling evidence for anyone with MS to quit smoking.  And we're breaking down the results of a study that analyzed mortality rates in cases where MS was listed as the underlying cause of death. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: When the roles of patient and care partner get turned upside down and inside out  :22 The FDA green lights clinical trials for an investigational drug that promises neuroprotection during an MS relapse   1:08 People living with MS who meet the medical criteria aren't jumping on the GLP-1 bandwagon   5:43 Study results provide startling evidence for quitting smoking if you're living with MS   8:34 In spite of highly effective DMTs, mortality rates for deaths in which MS is listed as the underlying cause are increasing  14:05 Kathleen Silva takes us through the harrowing time in her life when her husband, Rick, was diagnosed with MS shortly after she had been diagnosed with Stage 4 colon cancer and given just a 15% chance of surviving   19:23  Share this episode  35:12 Next week  36:31 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/468 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com STUDY: Use of Semaglutide and Tirzepatide Among People with Multiple Sclerosis https://journals.sagepub.com/doi/10.1177/13524585261442033 STUDY: Impact of Tobacco and Alcohol Consumption on Disease Progression and MRI In People With Multiple Sclerosis: Results of the Prospective Cohort Study NationMS https://journals.sagepub.com/doi/10.1177/17562864261464304 STUDY: Racial and Ethnic Trends and Comorbidity Patterns in Multiple Sclerosis Mortality https://www.neurology.org/doi/10.1212/WN9.0000000000000148 REGISTER: ECTRIMS Patient Community Day https://ectrimspatientcommunity.eu JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 468 Guest: Kathleen Silva Privacy Policy

Episode 26-32 Insulin Resistance- The "Silent Killer" You Probably Have, But Don't Know It Do you have Insulin Resistance? That's a question you should know the answer to. Why? Because Insulin Resistance is linked to nearly every major chronic disease. Diseases such as High Blood Pressure, Diabetes, Alzheimer's, Stroke, Parkinson's, Fibromyalgia, Multiple Sclerosis, Obesity, Heart Disease, and Autoimmune Disorders.  Insulin Resistance is also something very few doctors talk about. Why? I honestly don't know. But what I DO know is this: YOU need to know about Insulin Resistance… AND you need to know how to find out whether or not you have it. This is especially true if you are over the age of 30 as the majority of American adults HAVE Insulin Resistance and don't even know it! On this episode I talk about Insulin Resistance and how to determine if you have it. Give this episode a good listen and, as always, be sure to share it with a friend.  Thanks!  ———————- Want to learn more? Continue the conversation regarding this episode, and all future episodes, by signing up for our daily emails. Simply visit: GetHealthyAlabama.com  Once there, download the "Symptom Survey" and you will automatically added to our email list. ———————- Also, if you haven't already, we'd appreciate it if you'd subscribe to the podcast, leave a comment and give us a rating. (Thanks!!!)  

           * This podcast is for informational and educational purposes only. It is not intended to diagnose or treat any disease. Please consult with your health care provider before making any health-related changes.

Strategy with Sally is revisiting one of our most powerful conversations—this time with Allyson Brown, Director of Everheal, creator of the 4-Step LIFE Formula Program, and a PhD-trained analytical researcher who transformed her own life after overcoming Multiple Sclerosis. Joined by co-host Ash, Customer Success Manager, Sally sits down with Allyson to explore the deeply personal journey that led her from navigating her own health challenges to helping others take back control of their wellbeing. Allyson shares how her experience inspired her to help people break free from fatigue, brain fog, stubborn weight gain, inflammation, and autoimmune challenges—and why so many of us continue to put our health at the bottom of the priority list. In this episode, you'll discover: The warning signs that your body may be asking for a reset Why energy, inflammation, diet, mindset, and daily habits are all connected Practical ways to start prioritising your health without feeling overwhelmed Common misconceptions about health and wellness The influences and experiences that shaped Allyson's approach How small, sustainable lifestyle changes can create meaningful results What Allyson might be doing today if she hadn't pursued a career in health And, of course, we wrap things up with a fun Fast Talk round, where Allyson reveals her personal health and lifestyle preferences. Whether you're hearing this conversation for the first time or revisiting it, this episode is an important reminder: Your health deserves a promotion. If you've been putting your wellbeing on the back burner, let this conversation be your reminder—and your roadmap—to start making yourself a priority. Connect with Allyson & Everheal Everheal Website: www.everheal.com.au Facebook: www.facebook.com/everheal.com.au/ Instagram: www.instagram.com/everheal_/ LinkedIn: www.linkedin.com/in/allyson-brown-everheal/

Is Multiple Sclerosis (MS) truly an autoimmune disease—or could chronic infections and parasites play a much larger role than we've been led to believe?In this thought-provoking episode of the Functionally Enlightened Podcast, Dr. Sharon Surita sits down with Pam Bartha, founder of Live Disease Free and author of Become a Wellness Champion.Diagnosed with Multiple Sclerosis in 1988 and told to prepare for lifelong disability, Pam refused to accept that prognosis. Instead, she spent decades researching nutrition, chronic infections, gut health, parasites, and environmental stressors. More than 35 years later, she continues to live free from MS symptoms and has helped over 2,000 individuals across 15 countries explore a root-cause approach to chronic illness.Together, Sharon and Pam discuss why many chronic illness protocols fall short, the role of parasites and co-infections, and why supporting the body first may be essential before addressing deeper infectious burdens.In this episode you'll learn:✔ Why Pam believes MS has an infectious component✔ The relationship between parasites, gut health, and chronic inflammation✔ Why conventional parasite testing may miss many infections✔ The impact of microbiome disruption and antibiotic overuse✔ How diet may influence inflammation and immune function✔ Why mold, toxic burden, and environmental exposures matter✔ The importance of addressing the body as an interconnected system✔ Why mindset and consistency are essential during recoveryWhether you're living with MS, implant illness, autoimmune symptoms, neurological dysfunction, or another complex chronic condition, this conversation offers a different perspective on asking deeper questions and exploring potential root contributors to illness.Please note: The views expressed in this interview are those of the guest and are shared for educational purposes. They should not be interpreted as medical advice or as established scientific consensus regarding the causes or treatment of multiple sclerosis.Resources MentionedBecome a Wellness Champion by Pam Bartha

In this episode of Mind the Meds, host Erica Marini, PharmD, MS, BCPS, welcomes Jenelle Hall Montgomery, PharmD, BCACP, CPP, a clinical pharmacist practitioner with Duke Neurological Disorders Clinic at Duke University Hospital, to discuss highlights from the Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting in Charlotte, North Carolina, where Montgomery was recognized as a Giant of Multiple Sclerosis. Before the CMSC discussion, Marini runs through a roundup of recent neurology news, including approval of at-home initiation dosing for lecanemab-irmb (Leqembi; Eisai, Biogen), fast track designation for remlifanserin (Acadia Pharmaceuticals) in Alzheimer disease psychosis, approval of the oral PCSK9 inhibitor enlicitide (Lipfendra; Merck), and phase 3 data on tavapadon (AbbVie) for Parkinson disease showing a lower rate of impulse control disorders than traditional dopamine agonists.The pharmacists then turn to CMSC sessions on off-label and evolving areas of MS care. They discuss growing interest in neurofilament light chain as a biomarker for tracking subclinical disease progression over time, along with the ongoing debate over when it is safe to discontinue disease-modifying therapy (DMT) in older, stable patients. Both note their practices generally begin this conversation around 60 to 65 years of age, factoring in radiographic and clinical stability over the preceding decade, and describe strategies such as tapering dosing frequency or switching to lower-efficacy agents rather than abrupt discontinuation.The conversation closes with an update on family planning in MS, where new data presented at CMSC reinforce the safety of anti-CD20 therapies during pregnancy and breastfeeding. Montgomery and Marini review a 10-year dataset of about 5000 pregnancies on ocrelizumab (Ocrevus; Genentech), a large safety analysis of ofatumumab (Kesimpta; Novartis Pharmaceuticals) showing no increase in birth malformations, and early transfer-into-breastmilk data on ublituximab (Briumvi; TG Therapeutics). They also touch on the limited but growing evidence for GLP-1 receptor agonists in patients with MS, noting no known drug interactions with DMTs and possible indirect benefit through weight-related disease modulation, though neither pharmacist currently prescribes GLP-1s for an MS indication.Key Takeaways:1. Neurofilament light chain is emerging as a useful, though not yet mainstream, biomarker in MS. Rather than a single value, tracking neurofilament light chain over time alongside clinical status may help identify subclinical disease progression, particularly in patients without clear relapses.2. DMT discontinuation in older, stable patients remains individualized, with most practices starting the conversation around 60 to 65 years of age. Clinicians weigh 10-year clinical and radiographic stability, and some patients opt for a gradual step-down in dosing frequency or a switch to a lower-efficacy agent rather than outright discontinuation.3. New pregnancy and breastfeeding safety data continue to support anti-CD20 therapies as a preferred family planning strategy in MS. A 10-year, 5000-pregnancy dataset on ocrelizumab, reassuring malformation data on ofatumumab, and early breastmilk transfer data on ublituximab are strengthening patient counseling conversations around conception, pregnancy, and postpartum DMT resumption.

In part two of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the FENhance 1 and 2 trials looking at fenebrutinib in relapsing  MS.  For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting.  Read more about the Fenebrutinib Trial. 

In part two of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about the latest developments in BTK inhibitors for MS, including safety signals, trial results, and future directions.  For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting.  Read more about the Fenebrutinib Trial.  Disclosures can be found at Neurology.org. 

In part one of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the fenebrutinib trial and highlight the key takeaways that healthcare providers should be aware of.   For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting.  Read more about the Fenebrutinib Trial. 

In part one of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about recent multiple sclerosis clinical trial data.  For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting.  Read more about the Fenebrutinib Trial.  Disclosures can be found at Neurology.org.   

During his fellowship in the United States, Dr. Avinash Chandra trained to become an MS specialist at a world-class MS center. Then he returned home to Nepal and discovered that MS was largely considered non-existent. But Dr. Chandra knew it wasn't.  In this week's episode, Dr. Chandra discusses his experience creating a framework for MS care in Nepal that hadn't existed before. He also explains the necessary trade-offs in providing costly medical treatment in a country where the average family of four lives on an income of $500 a month.  It's been well-established that males living with MS tend to experience faster and more severe disease progression than females. We're sharing results of a study that shows clear differences in healthcare use by sex up to a decade before the onset of MS.  We'll tell you about a newly published review of 30 years of data measuring the efficacy of autologous hematopoietic stem cell transplantation (aHSCT). And we're sharing the registration details for ECTRIMS Community Patient Day (it's a free live and online event you won't want to miss!) We have a lot to talk about! Are you ready for RealTalk MS??! This Week: MS care in a country that considered MS non-existent  :22 A study analyzed sex differences in healthcare usage between males and females with MS up to a decade before the first MS symptom develops   1:45 30 years of accumulated data show significant benefits of autologous hematopoietic stem cell transplantation in treating relapsing forms of MS   6:17 It's time to support the National MS Society's $119.6 million active investment in MS research   9:32 Dr. Avniash Chandra discusses MS care in Nepal  12:43  Share this episode  35:40 Next week  36:01 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/465 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com STUDY: Sex Differences in Healthcare Use Before the First Multiple Sclerosis-Related Demyelinating Event https://www.msard-journal.com/article/S2211-0348(26)00396-2/fulltext PLAIN ENGLISH SUMMARY: Sex Differences in Healthcare Use Before the First Multiple Sclerosis-Related Demyelinating Event https://tremlettsmsresearchexplained.wordpress.com/2026/07/22/sex-differences-in-healthcare-use-before-the-first-multiple-sclerosis-related-demyelinating-event-explained LISTEN: Dr. Helen Tremlett Discusses the MS Prodrome https://realtalkms.com/321 STUDY: Autologous Stem Cell Transplantation for Multiple Sclerosis https://pubmed.ncbi.nlm.nih.gov/41482159 REGISTER: ECTRIMS Patient Community Day https://ectrimspatientcommunity.eu SUPPORT: National MS Society Research https://nationalmssociety.org/research JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 465 Guest: Dr. Avinash Chandra Privacy Policy

Richie Brave is joined by Julie Adenuga to discuss grime music as well as Roxy Murray, who speaks about lived experiences of Multiple Sclerosis. @1Xtra on socialProduced by Unedited for BBC Radio 1Xtra.

Multiple Sclerosis (MS) is a neurodegenerative disease that slowly breaks down the lining around the body's nervous system which weakens the body's internal signals. The longer someone with MS has it, the worse their symptoms get. There is no current cure for Multiple Sclerosis and no definitively known cause for the disease. In today's episode of Health 411, Dr Jonathan Karp and student producer Dan Loges delve into discussion about Multiple Sclerosis; a personal topic for both as Dr. Karp's mother had it, and Dan's grandfather had it. They discuss the disease and share stories about their personal experiences with this illness. Tune in to this weeks episode of Health 411 to learn more about the autoimmune disease, Multiple Sclerosis.

All Home Care Matters and our host, Lance A. Slatton were honored to welcome Rebekah Dowhy & David Beeton as guests to the show.   About Rebekah Dowhy:   Rebekah is the President of the Caregiving Support Network, a ministry offering prayer, community, and practical support to family caregivers. Her most important role was being a primary caregiver to her Mom, Sherrie who had Multiple Sclerosis for 21 years.   About David Beeton:   David is the Vice President of Programs for the Caregiving Support Network. He is also serving as a Congregational Care Prayer Director at his church: Experience Community Church in Cannon County, Tennessee. He was a caregiver for his wife Sherrie, who had Multiple Sclerosis for 21 years.   About Caregiving Support Network:   The Caregiving Support Network ministry equips churches to reach caregivers in their community through prayer, community, and practical help. By working with the Caregiving Support Network, churches can show an unreached people group the love of Jesus.

"We have to stay on top of it. There isn't a golden year where MS suddenly decides to be kind to us." Growing older is something we all experience. But when you live with Multiple Sclerosis, aging often raises a different question: Which changes are simply part of getting older, and which are caused by MS? In this episode, we reflect on a recent MS Views and News webinar featuring Dr. Aaron Boster—MS and Aging—that challenged us to think differently about aging with MS. We discuss disease-modifying therapies, protecting our functional reserve, and the healthy habits that can help preserve the life and abilities we have today. We also share updates from our recent neurology visits and infusion treatments, discuss adapting to changes in healthcare, and reflect on why community support remains one of the best resources for navigating life with MS. In this episode, we explore: Why aging and Multiple Sclerosis are often intertwined and why it can be difficult to tell them apart. What Dr. Aaron Boster shared about disease-modifying therapies and why they continue to matter as we grow older. The importance of protecting your functional reserve through exercise, nutrition, sleep, hydration, and healthy lifestyle choices. Our recent infusion experiences, changing treatment routines, and adapting to new healthcare challenges. Why support groups, shared experiences, and practical tips from others living with MS can make all the difference. Keep the conversation going What habits or routines have helped you age well while living with MS? We'd love to hear your story and learn what's worked for you. Connect with us through our website or at acoupletakesonms@gmail.com. *** Thank you for listening to A Couple Takes on MS. We're grateful you're moving forward with us one step, one roll, and one story at a time. If you enjoyed this episode, please consider following the podcast, leaving a rating or review, and sharing it with someone who could use a little encouragement today.

If you've spent any time at all living with or caring for someone with multiple sclerosis, you know that medical textbooks and information-filled websites can give us facts, figures, and symptoms, but they rarely capture the sometimes messy, sometimes overwhelming, and sometimes darkly funny reality of what it actually feels like to get a diagnosis of MS and realize your life has suddenly shifted under your feet. Our guest, Liat Shalom, was diagnosed with MS in 2021, at the age of 30. Instead of letting that diagnosis define her, Liat picked up her pen and created Unravelled—a groundbreaking graphic memoir that refuses to sugar-coat the MS experience.   For about five years, we've known that the Epstein-Barr virus (EBV) triggers MS. We'll explain what biologists just discovered about how EBV triggers MS, and what that could mean for future treatments. We're sharing evidence from an important study that shows a simple blood test is as accurate as MRI in determining whether someone is experiencing a relapse or a pseudo-relapse. We're sharing details of a study showing that virtual reality (VR) therapy is effective in treating MS-related brain fog. And if you're a woman between the ages of 45 and 60 and you're experiencing perimenopause, we'll share an easy way for you to participate in MS research without leaving home. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: Unravalled, Liat Shalom's darkly humorous graphic novel about her MS journey  :22 Scientists discover how the Epstein-Barr virus triggers MS  1:53 A simple blood test can determine whether someone is experiencing a relapse or a pseudo-relapse  4:08 It's time to support the National MS Society's $119.6 million active investment in MS research   6:58 Virtual reality therapy can improve MS-related brain fog   9:16 An opportunity to participate in MS research for women between 45-60 who are experiencing perimenopause  11:41 Liat Shalom discusses her journey to an MS diagnosis that led her to create Unravalled, a darkly humorous graphic memoir  13:11  Share this episode  30:32 Next week  30:52 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/464 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com Unravelled: The Story of an MS Warrior by Liat Shalom https://unraveledgraphicnovel.com STUDY: CD4+ T-Cells Reactive to Epstein-Barr Virus Late Lytic Antigens are Enriched in Individuals with Multiple Sclerosis https://www.science.org/doi/10.1126/scitranslmed.adz6566 STUDY: Utility of Multi-Analyte Protein Assay to Distinguish Multiple Sclerosis Clinical Relapse from Pseudoexacerbation https://link.springer.com/article/10.1007/s40120-026-00984-2 STUDY: Effectiveness of Immersive and Non-Immersive Virtual Reality Interventions on Cognitive Function in People with Multiple Sclerosis: A Systematic Review https://www.mdpi.com/2077-0383/15/12/4534 PARTICIPATE IN RESEARCH: Perimenopause and Multiple Sclerosis https://www.nationalmssociety.org/news-and-magazine/news/ms-study-alert-perimenopause-survey STUDY: Effectiveness of Immersive and Non-Immersive Virtual Reality Interventions on Cognitive Function in People with Multiple Sclerosis: A Systematic Review https://www.mdpi.com/2077-0383/15/12/4534 SUPPORT: National MS Society Research https://nationalmssociety.org/research JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 464 Guest: Liat Shalom Privacy Policy

Pentagon plans widespread testosterone screening for troops; New study claims arthroscopic surgery for age-related degenerative changes of knees is worthless; Widely touted “precision” proton therapy doesn't outperform conventional radiation treatment for prostate cancer; Comparing the effectiveness of gummies and liquids vs. tablet or capsule forms of supplements; Supplements to lower LDL; Lithium orotate for Alzheimer's prevention; Novel ultrasound treatment may target inflammation in osteoarthritis; Researchers explore antiviral treatments for multiple sclerosis.  

Panelists: Josh Anderson, Belva Smith and Brian Norton ATFAQ205: Q1. Multiple Sclerosis and office work, Q2. Sensory tools for loud environments, Q3. Screen Mag and accessibility tools for the computer, Q4. TBI memory and organizational tools, Q5. Future of autonomous transportation

Dr. Hoffman continues his conversation with Dr. David Chernoff, Chief Medical Officer of Setpoint Medical.

Dr. David Chernoff, Chief Medical Officer of Setpoint Medical, discusses electrically driven vagus nerve stimulation (VNS) as a “neuroimmune modulation” approach to autoimmune and inflammatory disease. Chernoff explains the vagus nerve's sensory role in monitoring organs and signaling the brainstem and spleen to regulate immune responses, and how precise stimulation can reduce pro-inflammatory cytokines without immunosuppression. Setpoint's miniaturized, wireless, MRI-compatible implant is placed in an outpatient 45-minute neck procedure and delivers one minute of daily stimulation titrated to an upper comfort level; long-term safety is supported by prior surgical experience and a 242-patient blinded RA study with two-year data, leading to FDA approval for rheumatoid arthritis. The discussion covers add-on use with medications, potential steroid tapering, reimbursement, and research in Crohn's disease, relapsing MS (vision and remyelination), and other conditions, including psoriatic arthritis, lupus, and neurodegenerative diseases.

Living with depression has been described as "like living under a wet, heavy blanket". It can stop someone from showing up at work, meeting up with friends, and even connecting with their family.  One out of every two people living with MS will experience depression at some point in their MS journey. The METS for MS study is focused on a novel approach to treating major depressive disorder among people with MS -- one that doesn't require another infusion, injection, or pill. This week, Dr. Robert Motl, principal investigator for the METS for MS study, joins us to explain what the study is about and what his team is learning.  And Kelly, who lives with progressive MS, joins us to share how her participation in the study became life-changing.  We'll also tell you about the $500,000 donation to MS research that Fernando Mendoza and his family just made. We're sharing the details about the CAR-NKT cell therapy for MS that's being developed at UCLA. You'll learn about the novel nanoparticle therapy for MS that's being developed by a team at Syracuse University's BioInspired Institute. And we're sharing the surprising results of a study that measured the effectiveness of Rituximab versus Ocrevus.  We have a lot to talk about! Are you ready for RealTalk MS??! This Week: A study focusing on a novel approach to treating MS-related depression  :22 Fernando Mendoza and his family donate $500,000 to MS research  1:18 UCLA research team receives a $7.49 million dollar grant to develop CAR-NKT therapy for MS  2:22 Syracuse University research team receives NIH grant to develop novel nanoparticle therapy for MS   6:22 Study results: Rituximab and Ocrevus were compared head-to-head and the results are surprising   9:43 Dr. Robert Motl explains the Mood and Exercise Training Study for Multiple Sclerosis, and Kelly explains how her participation in the study turned out to be life-changing  14:22 Share this episode  35:43 Next week  36:03 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/463 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com STUDY: Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis https://www.nejm.org/doi/10.1056/NEJMoa2600993 PARTICIPATE: Mood and Exercise Training Study for Multiple Sclerosis (METS for MS) Email: METSforMS@uic.edu  Phone Ariel: (312) 355-1790 JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 463 Guest: Dr. Robert Motl, Kelly Privacy Policy

Dr. Bill Andrews is the Founder and CEO of Sierra Sciences; a company focused on finding ways to extend human lifespan and health span. Bill has been featured in Popular Science, The Today Show, The Doctor's TV Show, and numerous documentaries on the topic of life extension. Bill co-stars with Dr. Aubrey de Grey in the documentary “The Immortalists” that made it to the “Top-10-List” to receive an Oscar in 2014Bill is also an ultramarathon runner with over 100 ultramarathons under his belt. Bill believes that consistent and fun endurance exercise is one of the best ways to reduce inflammation and slow aging.Speaking at the Cell Surgical Conference 2024Bill's areas of research have included Dwarfism, Cancer, CardiovascularDisease, Inflammation, Osteoporosis, Anemia, Multiple Sclerosis,Aging, and many others. Before founding Sierra Sciences Bill was aMedical Researcher at Armos Corporation, Codon Corporation, BerlexBiosciences, Geron Corporation, and EOS Biotech. Bill played key rolesin the discoveries and inventions of:Human Growth Hormone (hGH), Prorennin (Prochymosin), Tissue Plasminogen Activator(tPA), Osteo-Inductive Factor (OIF), Thrombomodulin, Erythropoietin (EPO), Beta-Seron, HTSite Specific Mutagenesis, Various Cancer Treatments (Rytelo, Telomelysin, GV1001, UV1,mutant hTR, and others), Telomerase, TRAPeze, TA-65, hTERT mRNA RT-PCR HTS,Telomerase Gene Therapy, C0314818 (TAM818), TeloSMRT, Isagenesis (Product B), Premere, Telo-Vital, Rytelo, and many more.In 1997 Bill was awarded 2nd Place as National Inventor of the Year for his cancer research. In the early-to-mid 1990s, while at Geron Corporation, Bill led the research to discover both the RNA and protein components of human telomerase, the enzyme responsible forpreventing telomeres from shortening in our reproductive cells. He has determined that the only real definite “hard-stop” to lifespan and health span, that is true for all humans, as well as non-human primates, cats, dogs, horses, sheep, pig, and deer, is “Telomere Shortening”. No matter what else we do to treat aging, aging will neverbe cured and/or reversed unless we also solve the telomere shortening problem.Presently, the primary focus of Sierra Sciences is to find ways toproduce telomerase and lengthen telomeres in all cells of the humanbody, not just our reproductive cells, and eliminate this key hard-stop tosuper-longevity. But Bill is aware that the war against aging is not goingto be won with just one battle.Contact Dr. Bill Andrews:website: https://sierrasci.com/https://www.facebook.com/telomere.bill.andrewshttps://www.facebook.com/profile.php?id=61551532301673linkedin.com/in/billandrewsphdhttps://www.youtube.com/@billandrewsphdhttps://www.youtube.com/@sierrasciences1625https://www.instagram.com/yonderssi/Dr. Kimberley LinertSpeaker, Author, Broadcaster, Mentor, Trainer, Behavioral OptometristEvent Planners- I am available to speak at your event. Here is my media kit: https://brucemerrinscelebrityspeakers.com/portfolio/dr-kimberley-linert/To book Dr. Linert on your podcast, television show, conference, corporate training or as an expert guest please email her at incrediblelifepodcast@gmail.com or Contact Bruce Merrin at Bruce Merrin's Celebrity Speakers at merrinpr@gmail.com702.256.9199Host of the Podcast Series: Incredible Life Creator PodcastAvailable on...Apple: https://podcasts.apple.com/us/podcast/incredible-life-creator-with-dr-kimberley-linert/id1472641267Spotify: https://open.spotify.com/show/6DZE3EoHfhgcmSkxY1CvKf?si=ebe71549e7474663 and on 9 other podcast platformsAuthor of Book: "Visualizing Happiness in Every Area of Your Life"Get on Amazon: https://amzn.to/4cmTOMwWebsite: https://linktr.ee/DrKimberleyLinertThe Great Discovery eLearning platform: https://thegreatdiscovery.com/kimberleyl

Pointing to Edward's first symptom of Relapse–Remitting MS is tricky. From anxiety in his 20s, to poor sleep and numb hands, to back pain and difficulty walking, the road to diagnosis has been rocky. When he finally received confirmation—in the form of a terrifying MRI showing countless lesions on his brain and spine—Edward was a new father in his early 30s. Coming to terms with a lifelong condition that presents differently for everyone was a process that has slowly shifted his outlook on both his past and his future. In this episode, we speak with Edward about what his journey through symptoms and diagnosis looked like, and reflect on how facing down a debilitating illness can change your outlook on life if you let it. A musician from a young age, today Edward is exploring live performance with his solo project, Green Plastic Whistle, and facing an aversion to fame that derailed some previous opportunities. As he puts it, being told you have an unpredictable disease, that has the potential to impact anything from bladder function to your ability to see, really puts fear into perspective. With cautious optimism and a balanced take on the pros and cons of the medical system, Edward and Jesse delve into how you envision your future when you don't know what your health will hold. They explore the promising remyelination medications that have the MS community abuzz and what it's like to start a family in the midst of disease progression. Edward's experience with Multiple Sclerosis has given him a new perspective on how we prioritize our lives and what's possible when you begin to face the future without fear. Learn more about Edward's solo project, Green Plastic Whistle:  https://www.instagram.com/greenplasticwhistle/  Listen to Green Plastic Whistle on Spotify: https://open.spotify.com/user/0b6gv1y0qrwlp4bp3ztmusnsa?si=d557f3eb1a0947c2 https://www.youtube.com/watch?v=hV_reArTc7g Watch the episode on YouTube or Spotify, listen here on our website or on your favorite podcast platform. PODCAST LINKSWEBSITE: https://majorpainpodcast.comEMAIL: majorpainpodcast@gmail.comSUBSCRIBE: https://majorpainpodcast.com/subscribeSPOTIFY: https://open.spotify.com/show/5NDoD07WJmICdfdRKq0TyNAPPLE PODCASTS: https://podcasts.apple.com/us/podcast/major-pain/id1562947550?mt=2&ls=1 SOCIAL MEDIAINSTAGRAM: https://www.instagram.com/majorpainpodcastTIKTOK: https://www.tiktok.com/@majorpainpodcastYOUTUBE: https://www.youtube.com/@MajorPainPodcastFACEBOOK: https://www.facebook.com/majorpainpodcast AFFILIATE LINKSRARE PATIENT VOICE: https://rarepatientvoice.com/MajorPainPodcastAMAZON SHOP: https://www.amazon.com/shop/majorpainpodcastNEURAHEALTH: https://www.neurahealth.co/majorpain

On this episode of the podcast, we are joined by BJJ Black Belt and UFC veteran Professor Alberto Crane. Professor Crane discusses his start in BJJ in 1994 and eventually transitioning to fighting in early MMA events starting at King of the Cage, old school training in the 1990's, the evolution of BJJ in MMA, the evolution of BJJ in sport jiu-jitsu, how to make sport BJJ more exciting, overcoming his early struggles in BJJ competition, how to transfer success in the gym to success in tournaments, training for longevity, how getting diagnosed with Multiple Sclerosis has impacted his life, and Professor Crane's book titled "All In." You can check out his book here: All In: Lessons On and Off The Mat Thanks to the podcast sponsors: Datsusara, head over to https://www.dsgear.com/ and use the code Chewjitsu10 to get 10% off of the highest quality hemp gear for BJJ. Check out "Athlethc" at https://athlethc.com/ and use the code Chewjitsu10 to get 10% off of your order of hemp-derived THC performance mints.  Charlotte's Web CBD. Head over to https://bit.ly/chewjitsu30 and use the promo code Chewjitsu30 to get 30% off of your total purchase. Epic Roll BJJ. Check out https://epicrollbjj.com/ and use the promo code Chewjitsu20 to get 20% off of your total purchase. Check out podcast exclusives including conversations with guests, Q&A sessions, and tons more at https://patreon.com/thechewjitsupodcast

Jamie Lynn Sigler grew up in front of the world as Meadow Soprano, one of television's most iconic daughters. But while she was coming of age on screen, she was privately carrying a secret that almost nobody knew: at age 20, she was diagnosed with multiple sclerosis. For 14 years, she hid her diagnosis from Hollywood, her coworkers, and her friends out of fear and shame. Now, Jamie sits down with Hoda Kotb to pull back the curtain on a life no longer built on perfection, but on radical honesty. She opens up about her deeply moving memoir, And So It Is, which begins with a terrifying medical crisis involving her young son, Beau. Jamie shares how she broke through the paralyzing loop of childhood trauma through EMDR therapy, what it was like to finally confide in her late co star James Gandolfini, and how she found peace by letting go of the need to pretend she was always fine. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.